CAS NO: | 862891-27-8 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | CAY10583 is a potent and selective full Leukotriene B4 receptor type 2 (BLT2) agonist. CAY10583 directly promotes keratinocyte migrationin vitroand accelerates wound closurein vivo. CAY10583 is a promising pharmaceutical agent for diabetic wounds[1]. | ||||||||
IC50& Target[1] |
| ||||||||
体外研究 (In Vitro) | CAY10583 (1 nM-1μM; 24 hours) promotes wound closure via keratinocyte migration. And CAY10583 has no significant effect of on keratinocyte proliferation[1]. | ||||||||
体内研究 (In Vivo) | CAY10583 (administered topically to full-thickness wounds; 10 μM; 14 days) significantly results in a greater wound closure than the control group. The difference in wound closure between the CAY-treated group and the control group is pronounced over time until day 10. And the difference is approximately 6% at day 4 and reaches almost 20% at day 8. Notably, 100% closure was observed in the CAY-treated group at day 14[1].
| ||||||||
分子量 | 387.47 | ||||||||
Formula | C25H25NO3 | ||||||||
CAS 号 | 862891-27-8 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |